- Home
- CRNX vs ACGLO Comparison
CRNX vs ACGLO Comparison
Compare CRNX & ACGLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ACGLO
- Stock Information
- Founded
- CRNX 2008
- ACGLO N/A
- Country
- CRNX United States
- ACGLO Bermuda
- Employees
- CRNX N/A
- ACGLO 5800
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ACGLO Property-Casualty Insurers
- Sector
- CRNX Health Care
- ACGLO Finance
- Exchange
- CRNX Nasdaq
- ACGLO Nasdaq
- Market Cap
- CRNX 2.8B
- ACGLO N/A
- IPO Year
- CRNX 2018
- ACGLO N/A
- Fundamental
- Price
- CRNX $30.51
- ACGLO $20.44
- Analyst Decision
- CRNX Strong Buy
- ACGLO
- Analyst Count
- CRNX 10
- ACGLO 0
- Target Price
- CRNX $75.00
- ACGLO N/A
- AVG Volume (30 Days)
- CRNX 942.0K
- ACGLO N/A
- Earning Date
- CRNX 05-08-2025
- ACGLO N/A
- Dividend Yield
- CRNX N/A
- ACGLO N/A
- EPS Growth
- CRNX N/A
- ACGLO N/A
- EPS
- CRNX N/A
- ACGLO N/A
- Revenue
- CRNX $760,000.00
- ACGLO N/A
- Revenue This Year
- CRNX $343.70
- ACGLO N/A
- Revenue Next Year
- CRNX $733.93
- ACGLO N/A
- P/E Ratio
- CRNX N/A
- ACGLO N/A
- Revenue Growth
- CRNX N/A
- ACGLO N/A
- 52 Week Low
- CRNX $24.10
- ACGLO N/A
- 52 Week High
- CRNX $62.53
- ACGLO N/A
- Technical
- Relative Strength Index (RSI)
- CRNX 46.97
- ACGLO 45.54
- Support Level
- CRNX $29.05
- ACGLO $20.41
- Resistance Level
- CRNX $30.99
- ACGLO $20.60
- Average True Range (ATR)
- CRNX 1.43
- ACGLO 0.18
- MACD
- CRNX -0.09
- ACGLO 0.00
- Stochastic Oscillator
- CRNX 32.27
- ACGLO 33.77
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F
Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.